Immix Biopharma Inc (IMMX) financials · $640.7M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Immix Biopharma Inc (IMMX) $640.7M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$30.0M | -$22.7M |
| Net Income | -$29.4M | -$21.6M |
| EPS (Diluted) | -$0.89 | -$0.76 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $104.8M | $22.9M |
| Current Assets | $101.2M | $20.2M |
| Cash & Equivalents | $93.9M | $17.7M |
| PP&E | $2.52M | $1.74M |
| Total Liabilities | $11.0M | $9.70M |
| Current Liabilities | $10.1M | $8.69M |
| Shareholders' Equity | $93.8M | $13.3M |
| Retained Earnings | -$104.5M | -$75.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$23.9M | -$14.6M |
| CapEx | $732.9K | $1.18M |
| Investing Cash Flow | -$7.21M | -$1.18M |
| Financing Cash Flow | $107.4M | $15.9M |
| Net Change in Cash | $76.2M | $172.2K |
| Free Cash Flow | -$24.7M | -$15.8M |
FAQ
What is IMMX P/E and revenue?
Immix Biopharma Inc (IMMX) $640.7M cap.
What is IMMX revenue?
IMMX income-statement cache has no revenue figure yet.
Is IMMX profitable?
Immix Biopharma Inc last cached net income is -$29.4M (FY2025).
What are IMMX total assets?
Immix Biopharma Inc last cached total assets are $104.8M (FY2025).
What is IMMX free cash flow?
Immix Biopharma Inc last cached free cash flow is -$24.7M (FY2025).
Not investment advice. Cached statements, not a live tape.